First Trust Indxx Medical Devices ETF(MDEV.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
First Trust Indxx Medical Devices ETF
MDEV.US
News
View More

Waters Corporation Announces Merger with BD’s BDS Business

Waters Corporation has announced a merger with BD’s BDS Business, following a mutual confidentiality agreement signed in March 2025. The merger aims to provide cash proceeds to BD to maintain or reduce its net leverage. Both companies expect significant revenue and cost synergies, particularly in cross-selling Waters products and promoting LC-MS in clinical diagnostics. This announcement is for informational purposes only and should not be considered financial or legal advice.

Reuters·
US
WAT
-1.83%
Reuters·
US
WAT
-1.83%

BUZZ-Truist Securities downgrades Penumbra on Boston Scientific's $14.5 billion buyout

Truist Securities downgrades medical equipment maker Penumbrato “hold” from “buy” Boston Scientificsaid on Thursday that it will buy PEN in a deal valued at about $14.5 billionWe don’t see any major hurdles to this deal closing and believe it will be hard to top BSX given the smooth strategic fit, brokerage says11 of 19 brokerages rate the stock “buy” and 8 “hold”; their median PT is $370Including session’s move, PEN up 34% in the last 12 months

Reuters·
US
PEN
+0.08%
Reuters·
US
PEN
+0.08%

Penumbra (NYSE:PEN) Downgraded to "Hold" Rating by Wells Fargo & Company

Wells Fargo & Company has downgraded Penumbra (NYSE:PEN) from a "strong-buy" to a "hold" rating. This change follows a series of mixed ratings from other analysts, with some maintaining a buy rating and others downgrading their outlook. Currently, Penumbra has a consensus rating of "Moderate Buy" with an average price target of $354.38. The stock opened at $350.53, with a market cap of $13.73 billion and a P/E ratio of 83.86. Recent insider trading shows significant share sales by company directors.

Market Beat·
US
PEN
+0.08%
Market Beat·
US
PEN
+0.08%

This JM Smucker Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top Wall Street analysts have downgraded several stocks. Morgan Stanley's Megan Alexander downgraded J M Smucker Co from Overweight to Equal-Weight, lowering the price target from $115 to $105. Truist's Richard Newitter downgraded Penumbra Inc from Buy to Hold, raising the price target from $370 to $374. B of A's Daria Nasledysheva downgraded Ermenegildo Zegna NV from Buy to Neutral, lowering the price target from $11.5 to $11.2. Morgan Stanley's Stephen Grambling downgraded Marriott Vacations Worldwide Corp from Equal-Weight to Underweight, lowering the price target from $70 to $52. Deutsche Bank's Nate Svensson downgraded Shift4 Payments Inc from Buy to Hold, slashing the price target from $100 to $65.

benzinga_article·
US
FOUR
-2.28%
US
VAC
-4.18%
US
SJM
-2.61%
benzinga_article·
US
FOUR
-2.28%
US
VAC
-4.18%
US
SJM
-2.61%

U.S. stock market update: Boston Scientific acquires Penumbra for $14.5 billion, stock price surges 12.15%, attracting market attention!

Penumbra rose 12.15%; Boston Scientific fell 4.60%, with a trading volume of USD 1.308 billion; Intuitive Surgical fell 1.34%, with a trading volume of USD 338 million; Abbott fell 0.82%, with a trading volume of USD 253 million; Stryker rose 0.37%, with a market capitalization of USD 137.9 billion

Tracking Unusual Activity·
US
PEN
+0.08%
Tracking Unusual Activity·
US
PEN
+0.08%
© 2026 Longbridge｜Disclaimer